Charles River Laboratories Study Coordinator 1 - Study Directors - Drug Discovery in Mattawan, Michigan
Study Coordinator 1 - Study Directors - Drug Discovery
Req ID #: 37597
Mattawan, MI, US, 49071
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work e perform. In return, we’ll help you build a career that you can feel passionate about.
We are seeking an experienced Study Coordinator 1 for our Study Directors - Drug Discovery Team (ET/Surgery; for Ophthalmology studies)located in Mattawan, MI.
A Study Coordinator 1 is responsible for: provideing administrative and scientific support for non-clinical studies including, but not limited to, pre-study tasks (such as study outline and protocol development, pricing, scheduling, IACUC approvals, etc.). In addition, the individual will be responsible for monitoring the in-life progress of studies, as well as on-going review of in-life data to spot potential trends/effects, and other similarly related duties as assigned.
The following are minimum requirements related to the Study Coordinator 1 position.
HS/GED and 6 years MPI Research-relevant experience in Laboratory Operations, Quality Assurance, or Report Services; or
Bachelor’s degree and 2 years MPI Research-relevant experience in Laboratory Operations, Quality Assurance, or Report Services.
Basic familiarity with Microsoft Office Suite.
Computer skills, commensurate with Essential Functions and including ability to learn a validated system.
Ability to work extended hours beyond normal work schedule to include, but not limited to, evenings, weekends, extended shifts and/or extra shifts, sometimes on short notice.
Ability to work under specific time constraints.
About MPI Research, a Charles River Company
MPI Research is a premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies worldwide.
About Safety AssessmentCharles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles RiverCharles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 70% of the drugs approved by the FDA in 2016.
For more information, please visitwww.criver.com.
Charles River Laboratories, Inc. is an Equal Opportunity Employer M/F/Disabled/Vet